home / stock / nby / nby news


NBY News and Press, NovaBay Pharmaceuticals Inc. From 11/23/20

Stock Information

Company Name: NovaBay Pharmaceuticals Inc.
Stock Symbol: NBY
Market: NYSE
Website: novabay.com

Menu

NBY NBY Quote NBY Short NBY News NBY Articles NBY Message Board
Get NBY Alerts

News, Short Squeeze, Breakout and More Instantly...

NBY - NovaBay Pharmaceuticals Expands Avenova's Geographic Reach to Australia with New Exclusive Distribution Agreement

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova ® for the eye care market, announces the signing of an agreement with Paragon Care Group Australia Pty Ltd for the exclusive distribution of Avenova ...

NBY - 5 Penny Stocks To Watch Before Next Week; 3 Up Big In November 2020

Why Should You Pay Attention to These Penny Stocks Right Now? When it comes to penny stocks , finding the biggest gainers of the day can be a good step in the right direction. This allows investors to see what type of momentum a penny stock has. In addition, it can help to identify ...

NBY - NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q3 2020 Results - Earnings Call Transcript

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2020 Earnings Conference Call Nov 12, 2020, 04:30 PM ET Company Participants Jody Cain - VP, LHA Justin Hall - President & CEO Andrew Jones - CFO & Treasurer Conference Call Participants Edward Woo - Ascendiant Capital Presentation Operator Welco...

NBY - NovaBay EPS misses by $0.04, misses on revenue

NovaBay (NBY): Q3 GAAP EPS of -$0.08 misses by $0.04.Revenue of $2.17M (+34.0% Y/Y) misses by $0.35M.Shares -1.4%.Press Release For further details see: NovaBay EPS misses by $0.04, misses on revenue

NBY - NovaBay Pharmaceuticals Reports Third Quarter 2020 Financial Results

Revenue increased 34% versus prior year Avenova ® unit sales set quarterly record Exited Q3 with $13.4 million in cash and equivalents Regained compliance with NYSE American continued-listing standards Launches CelleRx ® Clinical Res...

NBY - NovaBay Announces Consumer Launch of CelleRx® Clinical Reset(TM)

Company enters beauty market with the launch of Clinical Reset as an expansion of the CelleRx brand NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces the consumer launch of Clinical Reset, an FDA-cleared skincare product proven to help clean and reduce the bui...

NBY - NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November 12

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces it will report financial results for the three and nine months ended September 30, 2020 after market close on Thursday, November 12, 2020 and will hold an investment community conference call that day at 4:30 p....

NBY - NovaBay +3.6% on regaining compliance with NYSE standards

NovaBay ([[NBY]] +3.2%) announces that it has regained full compliance with the NYSE listing standards after the company filed its Q2 reports.The Company was notified on April 12, 2019 that it was not in compliance with the NYSE American’s continued listing standards including the...

NBY - NovaBay Pharmaceuticals Regains Compliance with NYSE American Listing Standards

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces it believes that it has regained full compliance with the NYSE American’s continued listing standards, subject to NYSE American’s formal confirmation that the Company has regained compliance after...

NBY - Are These Premarket Penny Stocks To Buy Now Or Wait?

3 Penny Stocks To Trade Or Fade Before The Opening Bell Penny stocks are high-risk/high-reward, that’s a given. But are you familiar with premarket trading? If you’re new to trading, you may not know what time the market opens. While most will start trading “...

Previous 10 Next 10